Walleye Trading Advisors »

Karyopharm Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $704k 96k 7.36

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Microsoft Corporation (MSFT)
Boston Scientific Corporation (BSX)
Spdr Gold Tr Gold Shs (GLD)
Bank of America Corporation (BAC)
Tesla Motors (TSLA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ford Mtr Note 3/1 (Principal)
Intuitive Surgical Com New (ISRG)

View all positions for Walleye Trading Advisors

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Opaleye Management
Affinity Asset Advisors
Susquehanna International
Vanguard Group
Ikarian Capital
Soleus Capital Management
Adage Capital Partners GP
Davidson Kempner Capital Management
Braidwell
Exome Asset Management
Ameriprise Financial
Boxer Capital Management
BlackRock
Geode Capital Management

View all funds holding Karyopharm Therapeutics